Vaxess Technologies Inc Headquarters
Looking for information about Vaxess Technologies Inc Headquarters? The links below have collected all the necessary data.
Vaxess Technologies - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/vaxess-technologies
- Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date Dec 18, 2011. Founders Fiorenzo Omenetto, Kathryn Kosuda, Livio Valenti, Michael Schrader, Patrick Ho. Operating Status Active. Last Funding Type Venture - Series Unknown. Legal Name Vaxess Technologies, Inc. Company Type For Profit. Contact Email [email protected]: 18 Dec, 2011
Vaxess Technologies Inc - Company Profile and News ...
- https://www.bloomberg.com/profile/company/0812997D:US
- Vaxess Technologies, Inc. develops and provides medical technologies. The Company offers vaccine manufacturers a opportunity to improve product stability, thereby enabling lower distribution costs ...Leader: Michael Schrader
Vaxess Technologies LinkedIn
- https://www.linkedin.com/company/vaxess-technologies
- Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform.
VAXESS TECHNOLOGIES INC SBIR.gov
- https://www.sbir.gov/sbc/vaxess-technologies-inc
- Project Summary/Abstract The World Health Organization estimates that influenza viruses cause serious illness in 3 to 5 million people and up to 650,000 deaths globally each year.
Vaxess Technologies, Inc. STEX
- https://startupexchange.mit.edu/node/4044
- Apr 13, 2020 · Vaxess Technologies is a venture-backed biotechnology company developing novel products based on its proprietary MIMIX microneedle delivery platform. Our lead program is a sustain-release flu microneedle patch. We also have a pipeline of undisclosed targets including mRNA, immun/ooncology and other in-house targets and in partnership with ...
VAXESS TECHNOLOGIES INC SBIR.gov
- https://www.sbir.gov/sbirsearch/detail/399425
- The broader impact / commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to provide a new vaccine for the COVID-19 pandemic.
Vaxess Technologies - Home Facebook
- https://www.facebook.com/VaxessTechnologies
- Vaxess Technologies Awarded NIH Grant of up to $2.85 Million to Drive MIMIX™ Sustained Release Vaccine Patch Into a 2022 Phase 1 Human Trial. Vaxess Technologies, Inc., a biotechnology company developing vaccines and therapeutics delivered through a next-generation sustained-release intrader.5/5(1)
Vaxxas - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/vaxxas
- Headquarters Regions Asia-Pacific (APAC), Australasia. Founded Date 2011. Operating Status Active. Last Funding Type Grant. Company Type For Profit. Phone Number 61282057379. Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
Millennium Leadership Fellows - Atlantic Council
- https://www.atlanticcouncil.org/programs/millennium-leadership-program/millennium-leadership-fellows/
- Fortune 500 executives and entrepreneurs; nonprofit CEO’s and founders; award winning artists, authors, scientists, and academics; and senior government officials including mayors, members of parliament, ministers, advisors to heads-of-state, and others. These are just some of our fellows. 35 years old or younger, they already lead at a high level with decades of impact ahead in their careers.
Have you found Vaxess Technologies Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.